Similar articles

• Concerns regarding antidepressant drug use during pregnancy.

  Urato AC. Urato AC. J Psychiatry Neurosci. 2006 Nov;31(6):411; author reply 411-2. J Psychiatry Neurosci. 2006. PMID: 17136220 Free PMC article. No abstract available.
• The use of serotonin reuptake inhibitors in pregnancy.

  Malek-Ahmadi P. Malek-Ahmadi P. Can J Psychiatry. 2000 Dec;45(10):939-40. Can J Psychiatry. 2000. PMID: 11190370 No abstract available.
• Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.

  Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, Mitchell AA. Chambers CD, et al. N Engl J Med. 2006 Feb 9;354(6):579-87. doi: 10.1056/NEJMoa052744. N Engl J Med. 2006. PMID: 16467545
• Selective Serotonin Reuptake Inhibitors and Persistent Pulmonary Hypertension of the Newborn: An Update Meta-Analysis.

  Ng QX, Venkatanarayanan N, Ho CYX, Sim WS, Lim DY, Yeo WS. Ng QX, et al. J Womens Health (Larchmt). 2019 Mar;28(3):331-338. doi: 10.1089/jwh.2018.7319. Epub 2018 Nov 8. J Womens Health (Larchmt). 2019. PMID: 30407100 Review.
• Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis.

  Masarwa R, Bar-Oz B, Gorelik E, Reif S, Perlman A, Matok I. Masarwa R, et al. Am J Obstet Gynecol. 2019 Jan;220(1):57.e1-57.e13. doi: 10.1016/j.ajog.2018.08.030. Epub 2018 Aug 28. Am J Obstet Gynecol. 2019. PMID: 30170040